VOYA Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Buy |
41,390
+1,595
| +4% | +$7.45K | ﹤0.01% | 2338 |
|
|
2025
Q1 | $218K | Sell |
39,795
-4,958
| -11% | -$27.2K | ﹤0.01% | 2264 |
|
|
2024
Q4 | $152K | Sell |
44,753
-3,613
| -7% | -$12.2K | ﹤0.01% | 2473 |
|
|
2024
Q3 | $138K | Sell |
48,366
-366
| -0.8% | -$1.04K | ﹤0.01% | 2586 |
|
|
2024
Q2 | $110K | Buy |
48,732
+4,633
| +11% | +$10.4K | ﹤0.01% | 2640 |
|
|
2024
Q1 | $97.5K | Sell |
44,099
-11,778
| -21% | -$26K | ﹤0.01% | 2624 |
|
|
2023
Q4 | $131K | Buy |
55,877
+2,031
| +4% | +$4.77K | ﹤0.01% | 2691 |
|
|
2023
Q3 | $100K | Hold |
53,846
| – | – | ﹤0.01% | 2732 |
|
|
2023
Q2 | $141K | Buy |
53,846
+2,415
| +5% | +$6.33K | ﹤0.01% | 2698 |
|
|
2023
Q1 | $83.8K | Hold |
51,431
| – | – | ﹤0.01% | 2727 |
|
|
2022
Q4 | $68.4K | Hold |
51,431
| – | – | ﹤0.01% | 2815 |
|
|
2022
Q3 | $80.2K | Hold |
51,431
| – | – | ﹤0.01% | 2830 |
|
|
2022
Q2 | $79K | Buy |
+51,431
| New | +$79K | ﹤0.01% | 2678 |
|
|
2021
Q2 | – | Sell |
-20,975
| Closed | -$95K | – | 2910 |
|
|
2021
Q1 | $95K | Hold |
20,975
| – | – | ﹤0.01% | 2678 |
|
|
2020
Q4 | $103K | Buy |
20,975
+5,996
| +40% | +$29.4K | ﹤0.01% | 2555 |
|
|
2020
Q3 | $89K | Buy |
14,979
+1,776
| +13% | +$10.6K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $35K | Sell |
13,203
-193
| -1% | -$512 | ﹤0.01% | 2480 |
|
|
2020
Q1 | $26K | Hold |
13,396
| – | – | ﹤0.01% | 2570 |
|
|
2019
Q4 | $94K | Buy |
13,396
+3,382
| +34% | +$23.7K | ﹤0.01% | 2562 |
|
|
2019
Q3 | $98K | Hold |
10,014
| – | – | ﹤0.01% | 2419 |
|
|
2019
Q2 | $115K | Buy |
+10,014
| New | +$115K | ﹤0.01% | 2434 |
|